Cue Biopharma, Inc. (DUS:1UC0) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Frederick W. Driscoll Other companies: Lite Strategy, Inc. (Chairperson, Non-Executive Director · Since at least Feb 22, 2018); Cellectar Biosciences, Inc. (Director · Since at least Apr 10, 2017); Invivyd, Inc. (Interim CFO · Oct 13, 2022 – Oct 13, 2022 · Past); ConforMIS Inc (INTERIM CFO & INTERIM TREAS · Oct 23, 2019 – Oct 23, 2019 · Past); ImmunityBio, Inc. (Director · Sep 18, 2017 – Aug 11, 2020 · Past); Flexion Therapeutics Inc (Chief Financial Officer · Feb 11, 2014 – Nov 19, 2021 · Past); Oncotelic Therapeutics Inc (Director · Jan 1, 2014 – Jun 1, 2016 · Past); Novavax, Inc. (VP, CFO & Treasurer · Aug 24, 2009 – Mar 2, 2013 · Past); Genelabs Technologies Inc (CEO/PRESIDENT · Nov 1, 2007 – Jan 7, 2009 · Past) | Director · Jun 26, 2018 – Jan 2, 2025 · Past |
| Anthony DiGiandomenico Other companies: Illumination Acquisition Corp I (Director · Since at least Feb 26, 2026); ClearSign Technologies Corporation (Director · Since at least May 22, 2025); eXoZymes Inc. (Board Member · Since at least Nov 8, 2024); MDB Capital Holdings, LLC (Co-Founder, Head of New Venture Discovery · Since at least Jul 25, 2023); ENDRA Life Sciences Inc. (Director · Since at least May 8, 2017); Provention Bio Inc (Director · Jul 3, 2018 – May 15, 2020 · Past); Charlie's Holdings, Inc. (Director · Aug 4, 2006 – Aug 27, 2012 · Past) | Director · Dec 18, 2017 – Jan 2, 2019 · Past |
| Aaron G.L. Fletcher Other companies: Actuate Therapeutics, Inc. (Chairman · Since at least Aug 12, 2024); Cognition Therapeutics, Inc. (Director · Since at least Oct 7, 2021); IN8bio, Inc. (Director · Aug 16, 2022 – Dec 12, 2022 · Past); TFF Pharmaceuticals Inc (Director · Oct 24, 2019 – Dec 29, 2022 · Past); SWK Holdings Corp (Director · Sep 3, 2019 – Dec 31, 2021 · Past) | Director · Oct 3, 2019 – Jan 3, 2023 · Past |
| Shao-Lee Lin Other companies: Acelyrin, Inc. (Chief Executive Officer, Director · May 4, 2023 – Apr 1, 2024 · Past); Third Harmonic Bio Inc. (Director · Sep 14, 2022 – Oct 26, 2022 · Past); Surrozen, Inc. (Director · Aug 11, 2021 – May 14, 2025 · Past); Principia Biopharma Inc (Director · Apr 16, 2019 – Sep 28, 2020 · Past); Horizon Pharma PLC (EVP, Head of R&D and CSO · Jan 4, 2018 – Feb 20, 2019 · Past) | President, Chief Executive Officer and Board Director · Since at least Apr 30, 2026 |
| Sumita Ray Other companies: Biomea Fusion, Inc. (Director · Since at least Jun 16, 2021); Vaxxinity, Inc. (Chief Legal, Comp & Admin Off · Oct 1, 2023 – Nov 1, 2023 · Past); Instil Bio, Inc. (Chief Legal and Admin Officer · May 3, 2022 – Jan 8, 2023 · Past); Calithera Biosciences, Inc. (See Remarks · Sep 29, 2017 – Jan 25, 2022 · Past); Pharmacyclics Inc (Chief Compliance Officer · Jun 24, 2013 – Oct 31, 2013 · Past) | Chief Legal & Compliance Officer & Corporate Secretary · Since at least Jun 1, 2026 |
| Jill Marie Broadfoot Other companies: Talphera, Inc. (Director · Since at least Nov 20, 2021); aTyr Pharma, Inc. (Chief Financial Officer · Since at least Jul 30, 2018); Otonomy Inc (Director · Aug 18, 2021 – Jun 21, 2022 · Past); Vical Incorporated (Sr Vice President, CFO, Sec · Jan 7, 2011 – Apr 1, 2013 · Past) | Director · Since at least Jun 4, 2025 |
| Peter A Kiener Other companies: LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Palvella Therapeutics, Inc. (Director · Sep 7, 2018 – Jun 21, 2023 · Past); Sucampo Pharmaceuticals Inc (Chief Science Officer · Mar 4, 2015 – Feb 13, 2018 · Past); Medimmune Inc (SVP, Research · Feb 8, 2006 – Feb 23, 2006 · Past) | Director · Since at least Dec 18, 2017 |
| Tamar D Howson Other companies: Immunic, Inc. (Director · Since at least Oct 11, 2019); Lite Strategy, Inc. (Director · Jul 1, 2019 – Sep 29, 2023 · Past); VivoSim Labs, Inc. (Director · Jul 26, 2018 – Jul 26, 2018 · Past) | Director · Sep 17, 2020 – Jan 3, 2023 · Past |
| Barry Simon Other companies: ImmunityBio, Inc. (Chief Corporate Affairs Officer · Since at least Jul 27, 2015); Viracta Therapeutics Inc (Director · Mar 3, 2021 – Jun 20, 2024 · Past) | Director · Dec 18, 2017 – Jan 4, 2021 · Past |
| Cameron Gray Other companies: Provention Bio Inc (Director · Jul 3, 2018 – Jul 19, 2018 · Past); Endeavor IP Inc (CEO, CFO, Secretary, Treasurer, Director · May 13, 2013 – May 13, 2013 · Past) | Director · Dec 18, 2017 – Jun 14, 2022 · Past |
| Christopher Marlett Other companies: eXoZymes Inc. (Chairman of the Board · Since at least Nov 8, 2024); MDB Capital Holdings, LLC (Chief Executive Officer, Chairman of Board and Director · Since at least Jul 25, 2023) | Director · Dec 18, 2017 – Jan 2, 2020 · Past |
| Daniel Baker Other companies: Shattuck Labs, Inc. (Director · Since at least Aug 25, 2025); Artiva Biotherapeutics, Inc. (Director · Since at least Jan 28, 2025) | CHIEF DEVELOPMENT OFFICER · Since at least Nov 25, 2024 |
| James M. Ahlers Other companies: Intensity Therapeutics, Inc. (Executive Vice President · Since at least Jun 29, 2023); RenovoRx, Inc. (Chief Financial Officer · Jul 15, 2022 – Jul 15, 2022 · Past) | Chief Financial Officer · Since at least Jul 30, 2026 |
| Michael J Fox Other companies: Resonant Inc (Director · Feb 16, 2016 – Mar 28, 2022 · Past); Regional Health Properties, Inc. (Director · Oct 1, 2013 – Apr 24, 2018 · Past) | Director · Jun 5, 2024 – Jun 5, 2024 · Past |
| Daniel R Passeri Other companies: Curis, Inc. (Director · May 31, 2006 – Jan 19, 2016 · Past) | CHIEF EXECUTIVE OFFICER, Director · Dec 18, 2017 – Mar 21, 2025 · Past |
| Dominique Christian Borie Other companies: Kyverna Therapeutics, Inc. (See Remarks · Feb 7, 2024 – Feb 7, 2024 · Past) | Chief Medical Officer · Since at least Jul 13, 2026 |
| Frank Morich Other companies: Perspective Therapeutics, Inc. (Director · Since at least Feb 3, 2023) | Director · Since at least Jul 31, 2018 |
| Gary Schuman Other companies: MDB Capital Holdings, LLC (Head of Compliance · Since at least Nov 5, 2026) | Interim CFO · Dec 18, 2017 – Dec 18, 2017 · Past |
| Kenneth Pienta Other companies: Curis, Inc. (Director · Mar 7, 2013 – Feb 28, 2017 · Past) | Chief Medical Officer · Dec 18, 2017 – Mar 25, 2022 · Past |
| Agnes Lee | Chief Investor Relations & Communications Officer · Since at least Sep 20, 2026 |
| Anish Suri | PRESIDENT AND CSO · May 14, 2018 – Jun 5, 2024 · Past |
| Bethany Mancilla | SVP and Chief Business Officer · Aug 1, 2018 – Mar 6, 2019 · Past |
| Colin Sandercock | SVP, GENERAL COUNSEL · Since at least Dec 18, 2017 |
| Daniel Camardo | Board Member · Since at least May 30, 2026 |
| Dominic Borie | Chief Medical Officer & Head of Research & Development · Since at least Jul 13, 2026 |
| Kerri-Ann Millar | CHIEF FINANCIAL OFFICER · May 1, 2018 – Mar 21, 2025 · Past |
| Lucinda Warren | CHIEF BUSINESS OFFICER · Since at least Sep 3, 2024 |
| Matteo Levisetti | Chief Medical Officer · Jan 17, 2023 – Mar 21, 2025 · Past |
| Michael Vincent Meluzio | VP, Prin. Accounting Officer · Since at least Jun 1, 2026 |
| Pamela D. Garzone | Board Member · Since at least Apr 19, 2023 |
| Pasha Sarraf | Chairman of the Board · Since at least Mar 10, 2025 |
| Patricia Nasshorn | Chief Business Officer · Dec 15, 2021 – Feb 16, 2023 · Past |
| Patrick Verheyen | Director · Since at least Apr 11, 2023 |
| Rodolfo Chaparro | EVP, Head of Immunology · Dec 18, 2017 – Jul 23, 2018 · Past |
| Ronald D Seidel III | EVP, Head of R&D · Dec 18, 2017 – Jul 23, 2018 · Past |
| Ron Oyston | Chief Administrative Officer · Since at least Nov 4, 2026 |
| Steven L McKnight | Director · Dec 18, 2017 – Jan 6, 2020 · Past |
| Usman Azam | CHIEF EXECUTIVE OFFICER, Director · Since at least Sep 29, 2025 |
| Viola Meehan | Board Member · Since at least May 30, 2026 |